Paper
Paper
Search
Search
Ctrl+K
Publish
Home
Fund
Earn
Journal
Notebook
Lists
RSC
USD
About
Docs
Changelog
Terms
Privacy
Support
Vandetanib in patients with previously treated RET-rearra...
Vandetanib in patients with previously treated RET-rearranged advanced non-small-cell lung cancer (LURET): an open-label, multicentre phase 2 trial
By
Kiyotaka Yoh
16 more
Kiyotaka Yoh
·
Shingo Matsumoto
14 more
·
Kōichi Goto
November 5, 2016
0
Paper
Conversation
0
Reviews
0
Bounties
0
Paper
Paper
Search
Search
Ctrl+K
Publish
Home
Fund
Earn
Journal
Notebook
Lists
RSC
USD
About
Docs
Changelog
Terms
Privacy
Support
Sign in to comment
Add a comment...
Best
Journal
The Lancet Respiratory Medicine
Topics
#medicine
#cancer-biology
#internal-medicine
#open-label
#vandetanib
Show all topics
DOI
10.1016/s2213-2600(16)30322-8
